Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT05798897 |
Title | Efficacy of MT-601 in Patients With Relapsed/Refractory Lymphoma (APOLLO) |
Acronym | APOLLO |
Recruitment | Recruiting |
Gender | both |
Phase | Phase I |
Variant Requirements | No |
Sponsors | Marker Therapeutics, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
City of Hope | RECRUITING | Duarte | California | 91010 | United States | Details |
Colorado Blood Cancer Institute (Sarah Cannon) | RECRUITING | Denver | Colorado | 80218 | United States | Details |
University of Kansas Medical Center | RECRUITING | Kansas City | Kansas | 66160 | United States | Details |
Cornell | RECRUITING | New York | New York | 10065 | United States | Details |
Tennessee Oncology PLLC | RECRUITING | Nashville | Tennessee | 37203 | United States | Details |
Sarah Cannon Research Institute at St. David's South Austin | RECRUITING | Austin | Texas | 78704 | United States | Details |
University of Wisconsin Carbone Cancer Center | RECRUITING | Madison | Wisconsin | 53792 | United States | Details |